ArticleeLife2017

A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency.

Manabu Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.